Carboxypeptidase U (CPU, TAFIa, CPB2) in thromboembolic disease : what do we know three decades after its discovery?
Source
International journal of molecular sciences - ISSN 1422-0067-22:2 (2021) p.
Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke
Source
Journal of thrombosis and haemostasis - ISSN 1538-7933-18:12 (2020) p. 3325-3335
Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis
Source
Journal of thrombosis and haemostasis - ISSN 1538-7933-17:6 (2019) p. 878-884
Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different invitro models
Source
Journal of thrombosis and haemostasis - ISSN 1538-7933-16:10 (2018) p. 2057-2069
Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction
Source
Journal of thrombosis and haemostasis - ISSN 1538-7933-16:2 (2018) p. 342-348